These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 637641)

  • 21. Effect of furosemide on urinary acidification in distal renal tubular acidosis.
    Rastogi SP; Crawford C; Wheeler R; Flanigan W; Arruda JA
    J Lab Clin Med; 1984 Aug; 104(2):271-82. PubMed ID: 6747443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A physiologic-based approach to the evaluation of a patient with hyperkalemia.
    Palmer BF
    Am J Kidney Dis; 2010 Aug; 56(2):387-93. PubMed ID: 20493606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
    Schambelan M; Sebastian A
    Nephrologie; 1985; 6(3):135-7. PubMed ID: 3908957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proximal renal tubular acidosis: association with familial normaldosteronemic hyperpotassemia and hypertension.
    Farfel Z; Iaina A; Levi J; Gafni J
    Arch Intern Med; 1978 Dec; 138(12):1837-40. PubMed ID: 718349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined tubular dysfunction in medullary cystic disease.
    Chagnac A; Zevin D; Weinstein T; Hirsh J; Levi J
    Arch Intern Med; 1986 May; 146(5):1007-9. PubMed ID: 3516100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H; Paillard M; Prigent A; Leviel F; Bichara M; Gardin JP; Idatte JM
    Am J Nephrol; 1986; 6(4):253-62. PubMed ID: 3777034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperkalemia with mild ECF volume contraction: studies to provide a possible physiologic interpretation.
    Kamel KS; Halperin ML
    Clin Invest Med; 1994 Oct; 17(5):414-9. PubMed ID: 7867245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudohypoaldosteronism: case report and discussion of the syndrome.
    Throckmorton DC; Bia MJ
    Yale J Biol Med; 1991; 64(3):247-54. PubMed ID: 1788991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyporeninemia and hypoaldosteronism in diabetes mellitus.
    Perez GO; Lespier L; Jacobi J; Oster JR; Katz FH; Vaamonde CA; Fishman LM
    Arch Intern Med; 1977 Jul; 137(7):852-5. PubMed ID: 879919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Mehandru SK; Haroon A; Masud A; Shah J; Kaur S; Masud A; Hossain A; Asif A; Vachharajani TJ
    Saudi J Kidney Dis Transpl; 2020; 31(5):1134-1139. PubMed ID: 33229781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms in hyperkalemic renal tubular acidosis.
    Karet FE
    J Am Soc Nephrol; 2009 Feb; 20(2):251-4. PubMed ID: 19193780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect.
    Stahl RA; Kanz L; Maier B; Schollmeyer P
    Clin Nephrol; 1986 May; 25(5):245-8. PubMed ID: 3521998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of NH4Cl acidosis on the function of renin-angiotensin-aldosterone system in newborn infants.
    Adamovich K; Sulyok E; Jaton T; Guignard JP
    J Dev Physiol; 1992 Jul; 18(1):9-12. PubMed ID: 1287079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4 Q565E mutation.
    Mayan H; Mouallem M; Shaharabany M; Pauzner R; Farfel Z
    Am J Obstet Gynecol; 2005 Feb; 192(2):598-603. PubMed ID: 15696009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
    Kee CS; Choi JW; Chang DK; Ahn YH; Kim HJ
    J Korean Med Sci; 1993 Dec; 8(6):464-70. PubMed ID: 8179835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
    Bantle JP; Nath KA; Sutherland DE; Najarian JS; Ferris TF
    Arch Intern Med; 1985 Mar; 145(3):505-8. PubMed ID: 3883934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.